Company profile
Modern Biosciences Limited is a UK company with status active founded in 2005.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
AA | Transaction MzUyNTM5ODgyNWFkaXF6a2N4 | Paper/PDF filed
Published 08 Jun 2026 22:57
Last confirmation statement made up date
Last accounts made up date
CERTNM | Transaction MzQ0MTc0MTI4M2FkaXF6a2N4
Published 01 Nov 2024 11:18
Company registered at Companies House
1 May 2021 to 31 Oct 2024
Multiple sclerosis (MS) is the most common cause of progressive disability in young adults in the Western world. It can be a relentless, painful, and disabling condition. In a person with MS the immune system attacks the myelin sheath, a fatty protective coating that surrounds nerve fibres, which causes inflammation and injury to the sheath and ultimately...
1 Mar 2015 to 28 Feb 2018
Modern Biosciences' novel bone-protecting agents programme aims to develop a new treatment for rheumatoid arthritis (RA) and other osteoimmune disorders. Rheumatoid arthritis affects 1% of the population worldwide and up to 40% of patients don’t respond to current treatments. Modern Biosciences' compounds represent a new approach to treating RA via the re...
1 Dec 2012 to 31 May 2015
Modern Biosciences' anti-inflammatory programme aims to develop a new treatment for rheumatoid arthritis (RA) and related autoimmune disorders. Rheumatoid arthritis affects 1% of the population worldwide. However, up to 40% of patients don’t respond to current treatments. Modern Biosciences' compounds represent a new approach to treating RA that reduces i...
